Medical therapy versus TEVAR for uncomplicated type B aortic dissection
Author(s) -
Varinder Singh Bedi,
Pranati Swain,
Ajay Yadav
Publication year - 2019
Publication title -
indian journal of thoracic and cardiovascular surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.114
H-Index - 9
eISSN - 0973-7723
pISSN - 0970-9134
DOI - 10.1007/s12055-019-00837-8
Subject(s) - medicine , cardiothoracic surgery , aortic dissection , aortic repair , vascular surgery , cardiac surgery , surgery , medical therapy , dissection (medical) , aneurysm , aorta
The standard of care in uncomplicated acute type B aortic dissection (uTBAD) has been optimal medical management. Surgical repair and endovascular interventions are adjuncts in managing complicated type B dissection. Increasing safety and confidence in the thoracic endovascular aortic repair (TEVAR) and recent data indicating long-term complications in medical management of uTBAD has brought a shift in treatment approach. TEVAR at best remains controversial, yet there is a subset, which will definitely benefit from intervention.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom